Synthesis and Characterization of Amphiphilic Glycidol−Chitosan−Deoxycholic Acid Nanoparticles as a Drug Carrier for Doxorubicin

Citations Over TimeTop 10% of 2010 papers

Abstract

Novel amphiphilic chitosan derivatives (glycidol-chitosan-deoxycholic acid, G-CS-DCA) were synthesized by grafting hydrophobic moieties, deoxycholic acid (DCA), and hydrophilic moieties, glycidol, with the purpose of preparing carriers for poorly soluble drugs. Based on self-assembly, G-CS-DCA can form nanoparticles with size ranging from 160 to 210 nm, and G-CS-DCA nanoparticles maintained stable structure for about 3 months when stored in PBS (pH 7.4) at room temperature. The critical aggregation concentration decreased from 0.043 mg/mL to 0.013 mg/mL with the increase of degree of substitution (DS) of DCA. Doxorubicin (DOX) could be easily encapsulated into G-CS-DCA nanoparticles and keep a sustained release manner without burst release when exposed to PBS (pH 7.4) at 37 °C. Antitumor efficacy results showed that DOX-G-CS-DCA have significant antitumor activity when MCF-7 cells were incubated with different concentration of DOX-G-CS-DCA nanoparticles. The fluorescence imaging results indicated DOX-G-CS-DCA nanoparticles could easily be uptaken by MCF-7 cells. These results suggested that G-CS-DCA nanoparticles may be a promising carrier for DOX delivery in cancer therapy.

Related Papers

• → Bile Acid Metabolism In Cirrhosis(1975)39 cited
• → Ratio of primary and secondary bile acids in feces(1999)27 cited
• Synthesis of some cholic acid and deoxycholic acid oximes(2010)
• → The in vitro transformation of deoxycholic acid into cholic acid with ferroascorbate system(1965)7 cited
• → Excretion and Nature of Bile Acids Formed from Cholic Acid‐24‐14C and Deoxycholic Acid‐24‐14C in Bile Duct Ligated Rats(1959)1 cited